Cart
sales@molnova.com
Tyr-Gly-Gly-Phe-Met-OH
CAS No. 58569-55-4
Tyr-Gly-Gly-Phe-Met-OH( Met-Enkephalin | Methionine enkephalin )
Catalog No. M20687 CAS No. 58569-55-4
Tyr-Gly-Gly-Phe-Met-OH is a naturally occurring endogenous opioid peptide that inhibits tumor growth via binding to the opioid receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 30 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 49 | In Stock |
|
| 50MG | 77 | In Stock |
|
| 100MG | 122 | In Stock |
|
| 200MG | 179 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTyr-Gly-Gly-Phe-Met-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionTyr-Gly-Gly-Phe-Met-OH is a naturally occurring endogenous opioid peptide that inhibits tumor growth via binding to the opioid receptor.
-
DescriptionTyr-Gly-Gly-Phe-Met-OH is a naturally occurring endogenous opioid peptide that inhibits tumor growth via binding to the opioid receptor.
-
In Vitro——
-
In Vivo——
-
SynonymsMet-Enkephalin | Methionine enkephalin
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOpioid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number58569-55-4
-
Formula Weight573.66
-
Molecular FormulaC27H35N5O7S
-
Purity>98% (HPLC)
-
SolubilityDMSO:40 mg/mL (69.73 mM)
-
SMILESCSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O
-
Chemical NameD-tyrosylglycylglycyl-L-phenylalanyl-L-methionine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhao D Plotnikoff N Griffin N et al. Methionine enkephalin its role in immunoregulation and cancer therapy[J]. International Immunopharmacology 2016:S1567576916300509.
molnova catalog
related products
-
[Arg14,Lys15]Nocicep...
Highly potent and selective NOP receptor agonist (EC50 = 1 nM). Displays > 875-fold selectivity over opioid receptors (IC50 values are 0.32, 280, > 10000 and 1500 for NOP, μ, δ and κ receptors respectively). Longer lasting and 30-fold more potent than nociceptin in vivo; pronociceptive and inhibits locomotor activity.
-
Bevenopran
Bevenopran is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.
-
Alvimopan
A selective peripherally acting μ-opioid antagonist with IC50 of 1.7 nM for the treatment of postoperative ileus.
